ReviewCancers2020

Cancer Management during COVID-19 Pandemic: Is Immune Checkpoint Inhibitors-Based Immunotherapy Harmful or Beneficial?

Silvia Vivarelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.